HSBC Holdings’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-35,466
Closed -$17.4K 2906
2023
Q2
$17.4K Buy
35,466
+143
+0.4% +$117 ﹤0.01% 2524
2023
Q1
$41.3K Hold
35,323
﹤0.01% 2575
2022
Q4
$91K Buy
35,323
+11,751
+50% +$31K ﹤0.01% 2920
2022
Q3
$70K Hold
23,572
﹤0.01% 2789
2022
Q2
$116K Buy
23,572
+5,907
+33% +$30.9K ﹤0.01% 3015
2022
Q1
$126K Buy
17,665
+5,939
+51% +$49.1K ﹤0.01% 3087
2021
Q4
$215K Buy
+11,726
New +$253K ﹤0.01% 2995

Other funds holding CELL

HSBC Holdings's CELL Position: Q3 2023 in Review

HSBC Holdings sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 35,466 shares — an estimated $17.4K sold.

HSBC Holdings first reported a position in CELL in Q4 2021 and held it in 7 quarters. The position peaked at $215K in Q4 2021. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • HSBC Holdings reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 35,466 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $17.4K.
  • HSBC Holdings first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 7 quarters.
  • HSBC Holdings's PhenomeX Inc. Common Stock position peaked at $215K in Q4 2021.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.